healthletics oral bpc-157 Is Banned? vs. Injectable Forms Explained Body Protection Compound (BPC-157) –

The mechanism of action for AOD 9604 involves stimulating fat breakdown and fat oxidation in adipose tissue, supporting research into its potential as a treatment for obesity and metabolic disorders

Evidence for genetic abnormalities in fibromyalgia has also been elucidated, with family studies showing that first-degree relatives of individuals with FMS display an eight-fold risk of developing the syndrome as compared to family members of patients with rheumatoid arthritis (RA)

The answer depends on your goals

Brzozowski, E

Our BPC-157 and TB-500 research kit consists of a single vial containing a precise 1:1 blend of both compounds, alongside a 10ml vial of Bacteriostatic Water for proper reconstitution and preservation